The overall picture which has emerged from numerous studies of c-myc expression during differentiation and development is that c-myc is associated with proliferation with some notable exceptions. These studies suggest a tightly regulated and complex role for c-Myc in differentiation and development; however, few of these studies have examined the c-Myc proteins. Recent reports and our preliminary studies reveal the continued presence of c-myc protein after differentiation of several different cell types. The goal of this proposal is to determine if there are changes in the synthesis, stability, localization and modification of the c-myc proteins during differentiation and growth inhibition and if alterations in synthesis and phosphorylation of c-myc can effect these processes. There are two major forms of c-myc which initiate at two distinct sites. Preliminary studies reveal that c-myc 1 can be synthesized independently of c-myc 2 (the exon 2 ATG-initiated protein) depending on the proliferation state. In addition c-myc 1 is differentially stabilized and localized in murine erythroleukemia cells. Therefore, it is possible that c-myc 1 may have a different role than c-myc 2 during differentiation and growth, perhaps as an antagonist to c-myc 2. The other major known characteristic of c-myc proteins is that they are all phosphorylated. Preliminary studies indicate that a major phosphorylation site in c-myc is in a highly conserved region which is frequently found to have mutations in 'activated"""""""" c-myc genes. This suggests that phosphorylation at this site may play a role in c-myc function. To test these hypotheses, changes in c- myc protein during differentiation of several cell types will be examined. Any observed differences will be compared with changes during growth inhibition due to TGF beta. To directly determine if c-myc synthesis or phosphorylation have roles in differentiation or growth inhibition, cell lines which overexpress c-myc mutants having altered initiation sites or phosphorylation sites will be developed. Finally, transgenic mice will be established with these c-myc mutants under the control of tissue-specific enhancers to examine the effects of altered synthesis or phosphorylation of c-myc protein in specific tissues during mouse embryogenesis. These studies should establish if there are any major differences in c-myc proteins during differentiation versus growth inhibition and help determine the role of any such differences on c-Myc function in differentiation and growth inhibition.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA048799-01A1
Application #
3817286
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37203
Satterwhite, D J; White, R L; Aakre, M E et al. (2001) TGF-beta1 regulates the expression of multiple max-interacting transcription factors in Balb/MK cells: implications for understanding the mechanism of action of TGF-beta1. Pediatr Res 50:67-75
Engel, M E; McDonnell, M A; Law, B K et al. (1999) Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. J Biol Chem 274:37413-20
Norgaard, P; Law, B; Joseph, H et al. (1999) Treatment with farnesyl-protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) alpha and TGF alpha/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosis. Clin Cancer Res 5:35-42
Lutterbach, B; Hann, S R (1999) c-Myc transactivation domain-associated kinases: questionable role for map kinases in c-Myc phosphorylation. J Cell Biochem 72:483-91
Gorska, A E; Joseph, H; Derynck, R et al. (1998) Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice. Cell Growth Differ 9:229-38
Alexandrow, M G; Moses, H L (1998) c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases. J Cell Biochem 70:528-42
Zhao, G Q; Liaw, L; Hogan, B L (1998) Bone morphogenetic protein 8A plays a role in the maintenance of spermatogenesis and the integrity of the epididymis. Development 125:1103-12
Engel, M E; Datta, P K; Moses, H L (1998) RhoB is stabilized by transforming growth factor beta and antagonizes transcriptional activation. J Biol Chem 273:9921-6
Datta, P K; Chytil, A; Gorska, A E et al. (1998) Identification of STRAP, a novel WD domain protein in transforming growth factor-beta signaling. J Biol Chem 273:34671-4
Spotts, G D; Patel, S V; Xiao, Q et al. (1997) Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins. Mol Cell Biol 17:1459-68

Showing the most recent 10 out of 62 publications